Your shopping cart is empty!
Clinical and Laboratory Standards Institute, 09/20/2002
Publisher: CLSI
File Format: PDF
$120.00$240.61
Published:20/09/2002
Pages:56
CLSI EP09-A2 addresses procedures for determining the bias between two clinical methods or devices, and for the design of a method comparison experiment using split patient samples and data analysis.
The U.S. Food and Drug Administration (FDA) has evaluated and recognized this approved-level consensus guidleine for use in satisfying a regulatory requirement.
Human Genetic and Genomic Testing Using Traditional and High-Throughput Nucleic Acid Sequencing Methods, MM09Ed3E
$100.00 $200.00
Evaluation of Qualitative, Binary Output Examination Performance, 3rd Edition, EP12Ed3E
$90.00 $180.00
Performance Standards for Antimicrobial Susceptibility Testing, 33rd Edition
Newborn Screening Follow-up; Approved Guideline - Third Edition, NBS02Ed3E
